ISOLF — Isodiol International Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $3.13m
- CA$22.25m
Annual balance sheet for Isodiol International, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2015 March 31st | 2016 March 31st | 2017 March 31st | 2018 March 31st | 2019 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 0.015 | 0.106 | 0.719 | 15.5 | 2.87 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.006 | 0.066 | 0.151 | 4.97 | 13.9 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 0.078 | 0.485 | 1.36 | 22.8 | 19.8 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0 | 0 | 0.059 | 1.06 | 1.62 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 0.078 | 0.485 | 2.28 | 54.5 | 23.6 |
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.416 | 1.23 | 0.375 | 6.7 | 11.5 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 0.416 | 1.23 | 0.375 | 6.7 | 16.7 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
ESOP Debt Guarantee | |||||
Other Equity | |||||
Total Equity | -0.338 | -0.743 | 1.9 | 47.8 | 6.93 |
Total Liabilities & Shareholders' Equity | 0.078 | 0.485 | 2.28 | 54.5 | 23.6 |
Total Common Shares Outstanding |